MYL has been the subject of several other reports. Wells Fargo & Co restated a hold rating on shares of Mylan in a report on Thursday, August 2nd. ValuEngine upgraded shares of Mylan from a strong sell rating to a sell rating in a report on Friday, August 3rd. Morgan Stanley lowered shares of Mylan from an overweight rating to an equal weight rating and decreased their price objective for the stock from $46.00 to $36.00 in a report on Tuesday, October 9th. Mizuho lowered shares of Mylan from a buy rating to a neutral rating in a research note on Friday, October 5th. Finally, Cantor Fitzgerald reiterated a hold rating and issued a $41.00 price target on shares of Mylan in a research note on Monday. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the company’s stock. Mylan currently has an average rating of Buy and an average price target of $46.87.
NASDAQ MYL traded down $0.20 during trading on Tuesday, hitting $36.95. The company had a trading volume of 322,957 shares, compared to its average volume of 6,361,761. The company has a current ratio of 1.26, a quick ratio of 0.77 and a debt-to-equity ratio of 1.10. Mylan has a one year low of $30.33 and a one year high of $47.82. The firm has a market capitalization of $18.78 billion, a PE ratio of 8.12, a price-to-earnings-growth ratio of 1.17 and a beta of 1.53.
Large investors have recently added to or reduced their stakes in the business. State of Alaska Department of Revenue increased its stake in Mylan by 5.3% during the 3rd quarter. State of Alaska Department of Revenue now owns 74,135 shares of the company’s stock valued at $2,712,000 after purchasing an additional 3,707 shares in the last quarter. Bellevue Group AG boosted its holdings in shares of Mylan by 114.7% during the 2nd quarter. Bellevue Group AG now owns 502,350 shares of the company’s stock valued at $18,155,000 after acquiring an additional 268,400 shares during the last quarter. Burney Co. boosted its holdings in shares of Mylan by 18.4% during the 2nd quarter. Burney Co. now owns 128,245 shares of the company’s stock valued at $4,635,000 after acquiring an additional 19,914 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of Mylan by 12.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 2,237,468 shares of the company’s stock valued at $80,863,000 after acquiring an additional 253,082 shares during the last quarter. Finally, Van ECK Associates Corp boosted its holdings in shares of Mylan by 16.7% during the 2nd quarter. Van ECK Associates Corp now owns 315,905 shares of the company’s stock valued at $11,417,000 after acquiring an additional 45,277 shares during the last quarter. Institutional investors and hedge funds own 82.99% of the company’s stock.
Mylan Company Profile
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.
Further Reading: Technical Analysis of Stocks, How Can It Help
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.